Clinical trial
Multicenter PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D - A Prospective Study on Total Indications
NCT04542577 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D - A Prospective Study on Total Indications
- Lead sponsor
- Aesculap AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 23, 2020
- Completion date
- January 25, 2024
- Enrollment
- 208 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative instability, post-discectomy syndrome, post-traumatic instabilities, spondylolisthesis